Cargando…
Clinicians’ opinions on recommending aspirin to prevent colorectal cancer to Australians aged 50–70 years: a qualitative study
OBJECTIVES: Australian guidelines recommend all adults aged 50–70 years old without existing contraindications consider taking low-dose aspirin (100–300 mg per day) for at least 2.5 years to reduce their risk of developing colorectal cancer. We aimed to explore clinicians’ practices, knowledge, opin...
Autores principales: | Milton, Shakira, McIntosh, Jennifer, Yogaparan, Thivagar, Alphonse, Pavithran, Saya, Sibel, Karnchanachari, Napin, Nguyen, Peter, Lau, Phyllis, Macrae, Finlay, Emery, Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925937/ https://www.ncbi.nlm.nih.gov/pubmed/33550247 http://dx.doi.org/10.1136/bmjopen-2020-042261 |
Ejemplares similares
-
Should I take aspirin? A qualitative study on the implementation of a decision aid on taking aspirin for bowel cancer prevention
por: Onwuka, Shakira, et al.
Publicado: (2023) -
Commentary: Pivoting during a pandemic: developing a new recruitment model for a randomised controlled trial in response to COVID-19
por: Milton, Shakira, et al.
Publicado: (2021) -
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial
por: Milton, Shakira, et al.
Publicado: (2021) -
The SYMPTOM‐upper gastrointestinal study: A mixed methods study exploring symptom appraisal and help‐seeking in Australian upper gastrointestinal cancer patients
por: Karnchanachari, Napin, et al.
Publicado: (2022) -
The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening
por: Emery, Jon D, et al.
Publicado: (2023)